PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21223996-5	2011	5-HT2A and 5-HT2B receptor agonist-induced pMF were both blocked by selective antagonists (ketanserin and SB206553, respectively), but not by antagonists to the other receptor subtype.	SB 206553	106-114	5-hydroxytryptamine receptor 2B	Rattus norvegicus	11-17	
20980537-10	2011	In contrast, inverse agonists (such as SB206553) that block constitutive activity at 5-HT(2B) or 5-HT(2C) receptors markedly reduced the LLRs, indicating the presence of constitutive activity in these receptors.	SB 206553	39-47	5-hydroxytryptamine receptor 2B	Rattus norvegicus	85-92	
9225307-9	1997	These behavioural profiles suggest that blockade of the 5-HT2A receptor may not reduce anxiety and demonstrate that 5-HT2B and/or 5-HT2C receptor subtypes may be primarily involved in the anxiolytic-like effects of mianserin and SB 206553 in rats.	SB 206553	229-238	5-hydroxytryptamine receptor 2B	Rattus norvegicus	116-122	
16495076-7	2006	SB 206553 (1 mg kg(-1) s.c.), a selective 5-HT2B/2C receptor antagonist, also inhibited the BW 723C86-mediated responses.	SB 206553	0-9	5-hydroxytryptamine receptor 2B	Rattus norvegicus	42-48